![Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group](https://www.ypsomed.com/files/media/02_Images/09_Press_Releases/Ajovy_Pen_CMYK_DE_ohneSchatten_low.png)
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
![Teva abandons Ajovy's cluster headache ambitions, clearing a path for Lilly to forge a new market | FiercePharma Teva abandons Ajovy's cluster headache ambitions, clearing a path for Lilly to forge a new market | FiercePharma](https://qtxasset.com/fiercepharma/1556112787/ajovy.jpg/ajovy.jpg?VersionId=FKwbfYrGZhERxgwIXt0SAUQODkBdTCu3)
Teva abandons Ajovy's cluster headache ambitions, clearing a path for Lilly to forge a new market | FiercePharma
![Lilly's experience and competitive advantage will establish Emgality in the migraine market: Global Data Lilly's experience and competitive advantage will establish Emgality in the migraine market: Global Data](https://www.biospectrumindia.com/uploads/articles/migraine-13820.jpg)
Lilly's experience and competitive advantage will establish Emgality in the migraine market: Global Data
![Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate injection) at European Academy of Neurology Congress | Business Wire Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate injection) at European Academy of Neurology Congress | Business Wire](https://mms.businesswire.com/media/20200521005736/en/739014/23/teva_RGB_JPEG.jpg)